{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:54:35Z","timestamp":1759452875945,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.imj.2025.100194","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T10:21:59Z","timestamp":1750587719000},"page":"100194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The growing interests in Epstein\u2013Barr virus: A bibliometric analysis of research trends, collaborations, and emerging hotspots"],"prefix":"10.1016","volume":"4","author":[{"given":"Lu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Arif","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1003-619X","authenticated-orcid":false,"given":"Jingwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-9969","authenticated-orcid":false,"given":"Qinjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6655-2463","authenticated-orcid":false,"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5974","key":"10.1016\/j.imj.2025.100194_bib0001","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/310207a0","article-title":"DNA sequence and expression of the B95-8 Epstein\u2013Barr virus genome","volume":"310","author":"Baer","year":"1984","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imj.2025.100194_bib0002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41541-022-00587-6","article-title":"Urgency and necessity of Epstein\u2013Barr virus prophylactic vaccines","volume":"7","author":"Zhong","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.imj.2025.100194_bib0003","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7326\/0003-4819-118-1-199301010-00009","article-title":"Epstein\u2013Barr virus infections: biology, pathogenesis, and management","volume":"118","author":"Straus","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.imj.2025.100194_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1059133","article-title":"EBV-associated diseases: current therapeutics and emerging technologies","volume":"13","author":"Chakravorty","year":"2022","journal-title":"Front Immunol"},{"issue":"7335","key":"10.1016\/j.imj.2025.100194_bib0005","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.imj.2025.100194_bib0006","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein\u2013Barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.imj.2025.100194_bib0007","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/cancers13061414","article-title":"EBV and the pathogenesis of NK\/T cell lymphoma","volume":"13","author":"Montes-Mojarro","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.imj.2025.100194_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037505","article-title":"Global and regional incidence, mortality and disability-adjusted life-years for Epstein\u2013Barr virus-attributable malignancies, 1990-2017","volume":"10","author":"Khan","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.imj.2025.100194_bib0009","first-page":"1","article-title":"Epstein\u2013Barr Virus and Kaposi\u2019s Sarcoma Herpesvirus\/Human herpesvirus 8","volume":"70","year":"1997"},{"issue":"5","key":"10.1016\/j.imj.2025.100194_bib0010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/cancers16050991","article-title":"Epigenetic mechanisms in latent Epstein\u2013Barr virus infection and associated cancers","volume":"16","author":"Torne","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.imj.2025.100194_bib0011","first-page":"405","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019","volume":"74","author":"Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"10.1016\/j.imj.2025.100194_bib0012","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.imj.2025.100194_bib0013","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin's lymphoma after infectious mononucleosis","volume":"349","author":"Hjalgrim","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.imj.2025.100194_bib0014","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/asi.23329","article-title":"Growth rates of modern science: A bibliometric analysis based on the number of publications and cited references","volume":"66","author":"Bornmann","year":"2015","journal-title":"J Assoc Inf Sci Technol"},{"issue":"3","key":"10.1016\/j.imj.2025.100194_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02129602","article-title":"Advanced bibliometric methods as quantitative core of peer review based evaluation and foresight exercises","volume":"36","author":"van Raan","year":"1996","journal-title":"Scientometrics"},{"issue":"10","key":"10.1016\/j.imj.2025.100194_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223994","article-title":"Visualizing a field of research: a methodology of systematic scientometric reviews","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.imj.2025.100194_bib0017","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","article-title":"How to conduct a bibliometric analysis: an overview and guidelines","volume":"133","author":"Donthu","year":"2021","journal-title":"J Bus Res"},{"issue":"6","key":"10.1016\/j.imj.2025.100194_bib0018","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1007\/s11192-021-03948-5","article-title":"The journal coverage of web of science, scopus and dimensions: a comparative analysis","volume":"126","author":"Singh","year":"2021","journal-title":"Scientometrics"},{"issue":"2","key":"10.1016\/j.imj.2025.100194_bib0019","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"issue":"1","key":"10.1016\/j.imj.2025.100194_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.joi.2014.12.001","article-title":"The relationship between the research performance of scientists and their position in co-authorship networks in three fields","volume":"9","author":"Bordons","year":"2015","journal-title":"J Informetr"},{"issue":"5","key":"10.1016\/j.imj.2025.100194_bib0021","doi-asserted-by":"crossref","first-page":"710","DOI":"10.15288\/jsad.2016.77.710","article-title":"Co-citation analysis of articles published in substance abuse journals: intellectual structure and research fields (2001-2012)","volume":"77","author":"Gonz\u00e1lez-Alcaide","year":"2016","journal-title":"J Stud Alcohol Drugs"},{"issue":"5","key":"10.1016\/j.imj.2025.100194_bib0022","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1213\/ane.0b013e31816d18a1","article-title":"Active research fields in anesthesia: a document co-citation analysis of the anesthetic literature","volume":"106","author":"Jankovic","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.imj.2025.100194_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104608","article-title":"Half a century of research on antipsychotics and schizophrenia: a scientometric study of hotspots, nodes, bursts, and trends","volume":"136","author":"Sabe","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.imj.2025.100194_bib0024","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/asi.22968","article-title":"Patterns of connections and movements in dual-map overlays: A new method of publication portfolio analysis","volume":"65","author":"Chen","year":"2014","journal-title":"J Am Soc Inf Sci Tec"},{"issue":"4","key":"10.1016\/j.imj.2025.100194_bib0025","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetr"},{"issue":"10","key":"10.1016\/j.imj.2025.100194_bib0026","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein\u2013Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.imj.2025.100194_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1289313","article-title":"Mechanisms of T cell evasion by Epstein\u2013Barr virus and implications for tumor survival","volume":"14","author":"Sausen","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.imj.2025.100194_bib0028","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.3390\/microorganisms7020048","article-title":"Extracellular vesicles in Epstein\u2013Barr Virus' Life cycle and pathogenesis","volume":"7","author":"Zhao","year":"2019","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.imj.2025.100194_bib0029","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/vaccines7030102","article-title":"The role of extracellular vesicles in viral infection and transmission","volume":"7","author":"Urbanelli","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.imj.2025.100194_bib0030","first-page":"355","article-title":"Immune evasion by Epstein\u2013Barr virus","volume":"391","author":"Ressing","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.imj.2025.100194_bib0031","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12250-017-3996-5","article-title":"An update: Epstein\u2013Barr virus and immune evasion via microRNA regulation","volume":"32","author":"Zuo","year":"2017","journal-title":"Virol Sin"},{"issue":"20","key":"10.1016\/j.imj.2025.100194_bib0032","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.3390\/cancers13205189","article-title":"Epstein\u2013Barr virus-associated malignancies and immune escape: the role of the tumor microenvironment and tumor cell evasion strategies","volume":"13","author":"Bauer","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.imj.2025.100194_bib0033","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","article-title":"The Basis of Oncoimmunology","volume":"164","author":"Palucka","year":"2016","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.imj.2025.100194_bib0034","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"10.1016\/j.imj.2025.100194_bib0035","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1182\/blood-2009-02-203687","article-title":"Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation","volume":"113","author":"Smith","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.imj.2025.100194_bib0036","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.191.10.1649","article-title":"Human CD4(+) T lymphocytes consistently respond to the latent Epstein\u2013Barr virus nuclear antigen EBNA1","volume":"191","author":"M\u00fcnz","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.imj.2025.100194_bib0037","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.oraloncology.2018.07.011","article-title":"Cellular-based immunotherapy in Epstein\u2013Barr virus induced nasopharyngeal cancer","volume":"84","author":"Lee","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.imj.2025.100194_bib0038","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ctrv.2018.02.008","article-title":"Immunotherapy in head and neck cancers: a new challenge for immunologists, pathologists and clinicians","volume":"65","author":"Outh-Gauer","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.imj.2025.100194_bib0039","first-page":"1152","article-title":"Expression of immune regulatory molecules in Epstein\u2013Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells","volume":"147","author":"Agathanggelou","year":"1995","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.imj.2025.100194_bib0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3892\/ijo.2023.5545","article-title":"Immunotherapy for nasopharyngeal carcinoma: current status and prospects (Review)","volume":"63","author":"Huang","year":"2023","journal-title":"Int J Oncol"},{"issue":"9","key":"10.1016\/j.imj.2025.100194_bib0041","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41591-021-01444-0","article-title":"Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial","volume":"27","author":"Mai","year":"2021","journal-title":"Nat Med."},{"issue":"4","key":"10.1016\/j.imj.2025.100194_bib0042","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1172\/JCI22053","article-title":"Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo","volume":"114","author":"Fu","year":"2004","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.imj.2025.100194_bib0043","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/jvi.66.5.2689-2697.1992","article-title":"Epstein\u2013Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts","volume":"66","author":"Brooks","year":"1992","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.imj.2025.100194_bib0044","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7774\/cevr.2024.13.1.21","article-title":"Current development of therapeutic vaccines for the treatment of chronic infectious diseases","volume":"13","author":"Park","year":"2024","journal-title":"Clin Exp Vaccine Res"},{"issue":"19","key":"10.1016\/j.imj.2025.100194_bib0045","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/1078-0432.CCR-14-1122-T","article-title":"A recombinant modified vaccinia ankara vaccine encoding Epstein\u2013Barr Virus (EBV) target antigens: a phase I trial in UNITED KINGDOM patients with EBV-positive cancer","volume":"20","author":"Taylor","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.imj.2025.100194_bib0046","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1158\/0008-5472.CAN-12-2448","article-title":"Phase I trial of recombinant modified vaccinia ankara encoding Epstein\u2013Barr viral tumor antigens in nasopharyngeal carcinoma patients","volume":"73","author":"Hui","year":"2013","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.imj.2025.100194_bib0047","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1007\/s12274-022-5254-x","article-title":"A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma","volume":"16","author":"Guo","year":"2023","journal-title":"Nano Res"},{"issue":"8","key":"10.1016\/j.imj.2025.100194_bib0048","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1248\/cpb.c16-00114","article-title":"The safety and immunological effects of rAd5-EBV-LMP2 vaccine in nasopharyngeal carcinoma patients: A phase I clinical trial and two-year follow-up","volume":"64","author":"Si","year":"2016","journal-title":"Chem Pharm Bull (Tokyo)"}],"container-title":["Infectious Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X25000334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X25000334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T18:12:41Z","timestamp":1759428761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772431X25000334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2772431X25000334"],"URL":"https:\/\/doi.org\/10.1016\/j.imj.2025.100194","relation":{},"ISSN":["2772-431X"],"issn-type":[{"type":"print","value":"2772-431X"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The growing interests in Epstein\u2013Barr virus: A bibliometric analysis of research trends, collaborations, and emerging hotspots","name":"articletitle","label":"Article Title"},{"value":"Infectious Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imj.2025.100194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}],"article-number":"100194"}}